AKBA vs EIX · rev $160.2M vs P/E 7.3, rev $17.60B
Akebia Ther (AKBA) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported AKBA revenue for 2024-12-31 was $160.2M. Net income was -$69.4M. Revenue was down 17.7% from 2023-12-31 to 2024-12-31. AKBA currently screens at market cap $260.1M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
AKBA currently screens at market cap $260.1M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the AKBA and EIX stock pages for the full models.
Not investment advice.